South Korean pharma invests $50 million in Axiom Space
Written by Jason Rainbow Thursday, 22 December 2022 16:36-
font size
decrease font size
increase font size
Write a comment
Boryung, a South Korean pharmaceutical company, has decided to invest $50 million in U.S. commercial space station developer Axiom Space’s Series C funding round.
The post South Korean pharma invests $50 million in Axiom Space appeared first on SpaceNews.